The Aporia
Wise, A. (2026, October 26). AI can help cure cancer, Anthropic suggests in filing for US stock market float. Evening Standard. https://www.standard.co.uk/news/tech/us-securities-and-exchange-commission-claude-american-b1302364.html
Wise, Anna. “AI can help cure cancer, Anthropic suggests in filing for US stock market float.” Evening Standard, 26 Oct. 2026, https://www.standard.co.uk/news/tech/us-securities-and-exchange-commission-claude-american-b1302364.html.
Wise, Anna. “AI can help cure cancer, Anthropic suggests in filing for US stock market float.” Evening Standard, October 26, 2026. https://www.standard.co.uk/news/tech/us-securities-and-exchange-commission-claude-american-b1302364.html.
Dated from the outlet's own feed. Check the original for its byline.
On October 26, Anthropic, the maker of AI chatbot Claude, filed for an initial public offering (IPO) on the US stock market, potentially raising up to $100 billion. The filing outlines both opportunities and risks associated with its technology, including the potential to cure diseases like cancer but also posing existential threats to humanity due to advanced AI's unpredictability. Anthropic’s IPO will be open to Australian investors as well, providing direct exposure to a company at the forefront of artificial intelligence development. However, the company’s 92-page risk document highlights concerns about AI dangers and societal impacts, which contrasts with typical investment prospectuses focused on financial rewards.